| Literature DB >> 33920606 |
Joan Torrent-Sellens1,2, Cristian Salazar-Concha3, Pilar Ficapal-Cusí1,2, Francesc Saigí-Rubió2,4.
Abstract
The lack of blood donors is a global problem that prevents the demand for blood prompted by an ageing population and increased life expectancy from being met. The aim of this study was to conduct an initial exploration of the reasons for using digital platforms in blood donation. Using a Theory of Planned Behaviour (TPB) framework, microdata for 389 participants from Latin American countries and Spain, and Partial Least Square-Structural Equation Modelling (PLS-SEM), the study obtained three main prediction paths. The first two started from feelings of trust in the digital community and a positive mood state associated with a modern lifestyle, and they were linked to attitudes and behavioural control in the explanation of the intention to donate and actual blood donation. The third path started from modern lifestyles, and was linked to the subjective norm in the prediction of intention and actual donation. These paths represent one of the very first attempts to predict intentions of donation and collaborative donation by taking a PLS-SEM approach. By determining the paths underpinning collaborative blood donors' motives, the results of this study provide strong support for the usefulness of the TPB model within the context of digital platform use and blood donation.Entities:
Keywords: Theory of Planned Behaviour; blood donation; collaborative exchanges; consumer behaviour; digital platforms
Year: 2021 PMID: 33920606 PMCID: PMC8073325 DOI: 10.3390/ijerph18084270
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Structural model (direct effects) of collaborative blood donation (CBD). Note: *** p = 0.001.
Summary of the measurement model.
| Latent Variable | Indicators | Internal Consistency Reliability | Convergent Validity | Discriminant Validity | |
|---|---|---|---|---|---|
| Composite Reliability | Loadings | AVE | HTMT Confidence Interval Does Not Include 1 | ||
| TRU | TRU1 | 0.946 | 0.958 | 0.897 | Yes |
| TRU3 | 0.936 | ||||
| MLS | MLS1 | 0.917 | 0.920 | 0.847 | Yes |
| MLS3 | 0.921 | ||||
| ATT | ATT1 | 0.913 | 0.915 | 0.778 | Yes |
| ATT2 | 0.921 | ||||
| ATT3 | 0.806 | ||||
| SBN | SBN1 | 0.935 | 0.940 | 0.877 | Yes |
| SBN3 | 0.934 | ||||
| PBC | PBC1 | 0.904 | 0.908 | 0.825 | Yes |
| PBC2 | 0.909 | ||||
| ICD | ICD1 | 0.909 | 0.896 | 0.833 | Yes |
| ICD2 | 0.930 | ||||
| CBD | CBD1 | 0.945 | 0.950 | 0.896 | Yes |
| CBD2 | 0.943 | ||||
Discriminant validity.
|
| |||||||
|
|
|
|
|
|
|
| |
|
| 0.882 | ||||||
|
| 0.320 | 0.947 | |||||
|
| 0.641 | 0.372 | 0.913 | ||||
|
| 0.665 | 0.213 | 0.576 | 0.920 | |||
|
| 0.607 | 0.258 | 0.545 | 0.604 | 0.908 | ||
|
| 0.522 | 0.371 | 0.583 | 0.485 | 0.454 | 0.937 | |
|
| 0.298 | 0.209 | 0.220 | 0.232 | 0.255 | 0.267 | 0.947 |
|
| |||||||
|
|
|
|
|
|
|
| |
|
| |||||||
|
| 0.370 | ||||||
|
| 0.779 | 0.435 | |||||
|
| 0.793 | 0.250 | 0.715 | ||||
|
| 0.742 | 0.308 | 0.685 | 0.752 | |||
|
| 0.611 | 0.425 | 0.694 | 0.578 | 0.552 | ||
|
| 0.342 | 0.231 | 0.250 | 0.268 | 0.302 | 0.302 | |
Notes: Diagonal (bold) items represent the square root of the AVE. The elements below the diagonal are correlations between constructs. The HTMT ratio with BC 95% confidence intervals was based on 500 subsamples.
Summary of the direct effects.
| Endogenous Variable Structural Path | Direct Effect | Bootstrap 95% CI 1 | Cohen’s f2 | |
|---|---|---|---|---|
| Attitudes (ATT) | 0.152 | 2.691 *** | [0.065;0.254 | 0.041 |
| Subjective norm (SBN) | 0.485 | 7.302 *** | [0.375; 0.590] | 0.308 |
| Perceived behavioural control (PBC) | 0.607 | 13.124 *** | [0.529; 0.681] | 0.585 |
| Intention of collaborative donation (ICD) | 0.353 | 5.590 *** | [0.254;0.461] | 0.176 |
| Collaborative blood donation (CBD) | 0.372 | 7.561 *** | [0.289; 0.448] | 0.160 |
Notes: *** p < 0.001. 1 All intervals are significant.
Summary of the indirect effects.
| Latent Variable | Indirect Effect | Bootstrap 95% CI 1 | ||
|---|---|---|---|---|
| 5% | 95% | |||
|
| 0.050 *** | 3.039 | 0.028 | 0.080 |
| PBC -> ICD -> CBD | 0.131 *** | 4.178 | 0.085 | 0.184 |
| ATT -> PBC -> ICD -> CBD | 0.080 *** | 3.556 | 0.048 | 0.118 |
|
| 0.012 ** | 2.196 | 0.005 | 0.022 |
| SBN -> ICD -> CBD | 0.157 *** | 4.763 | 0.103 | 0.212 |
|
| 0.076 *** | 3.293 | 0.043 | 0.102 |
| MLS -> ATT -> PBC -> ICD | 0.135 *** | 4.009 | 0.084 | 0.195 |
| ATT -> PBC -> ICD | 0.214 *** | 4.820 | 0.145 | 0.287 |
| TRU -> ATT -> PBC -> ICD | 0.033 ** | 2.221 | 0.012 | 0.059 |
| MLS -> SBN -> ICD | 0.205 *** | 4.237 | 0.131 | 0.289 |
| MLS -> ATT -> PBC | 0.383 *** | 6.510 | 0.281 | 0.480 |
| TRU -> ATT -> PBC | 0.092 ** | 2.629 | 0.035 | 0.150 |
Notes: *** p < 0.001; ** p < 0.05. 1 All intervals are significant. In bold, hypothesized indirect effects.